Intuitive Surgical, Inc. (ISRG)

Basic

  • Market Cap

    $109.79B

  • EV

    $103.4B

  • Shares Out

    352.07M

  • Revenue

    $6,850.8M

  • Employees

    12,120

Margins

  • Gross

    66.61%

  • EBITDA

    30.8%

  • Operating

    25.07%

  • Pre-Tax

    26.82%

  • Net

    22.14%

  • FCF

    18.33%

Returns (5Yr Avg)

  • ROA

    8.85%

  • ROE

    15.4%

  • ROCE

    15.72%

  • ROIC

    21.68%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $327.83

  • P/E

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

Per Share

  • Rev

    $19.52

  • Earnings (Dil)

    $4.25

  • FCF

    $3.52

  • Book Value

    $35.62

Growth (CAGR)

  • Rev 3Yr

    16.73%

  • Rev 5Yr

    13.93%

  • Rev 10Yr

    11.54%

  • Dil EPS 3Yr

    13.29%

  • Dil EPS 5Yr

    13.42%

  • Dil EPS 10Yr

    8.63%

  • Rev Fwd 2Yr

    13.98%

  • EBITDA Fwd 2Yr

    13.58%

  • EPS Fwd 2Yr

    17.35%

  • EPS LT Growth Est

    15.01%

Dividends

  • Yield

  • Payout

  • DPS

  • DPS Growth 3Yr

  • DPS Growth 5Yr

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM

Total Revenues

3,724.2

4,478.5

4,358.4

5,710.1

6,222.2

6,850.8

Total Revenues % Chg.

18.7%

20.3%

-2.7%

31.0%

9.0%

12.0%

Cost of Goods Sold, Total

1,120.1

1,368.3

1,497.2

1,751.6

2,026.2

2,287.8

Gross Profit

2,604.1

3,110.2

2,861.2

3,958.5

4,196.0

4,563.0

Selling General & Admin Expenses, Total

941.4

1,178.4

1,216.3

1,466.5

1,711.8

1,863.0

R&D Expenses

418.1

557.3

595.1

671.0

879.0

982.8

Other Operating Expenses, Total

1,359.5

1,735.7

1,811.4

2,137.5

2,590.8

2,845.8

Operating Income

1,244.6

1,374.5

1,049.8

1,821.0

1,605.2

1,717.2

Interest And Investment Income

75.8

116.8

103.5

80.8

106.0

216.6

Net Interest Expenses

75.8

116.8

103.5

80.8

106.0

216.6

Currency Exchange Gains (Loss)

6.1

4.9

-1.4

-0.9

-27.3

-52.1

Other Non Operating Income (Expenses)

39.1

EBT, Excl. Unusual Items

1,326.5

1,496.2

1,151.9

1,900.9

1,683.9

1,920.8

Gain (Loss) On Sale Of Investments

-1.8

6.0

55.1

-10.6

-49.0

-55.0

Legal Settlements

-45.2

-28.1

-28.1

EBT, Incl. Unusual Items

1,279.5

1,502.2

1,207.0

1,890.3

1,606.8

1,837.7

Income Tax Expense

154.5

120.4

140.2

162.2

262.4

294.4

Earnings From Continuing Operations

1,125.0

1,381.8

1,066.8

1,728.1

1,344.4

1,543.3

Minority Interest

2.9

-2.5

-6.2

-23.5

-22.1

-26.6

Net Income

1,127.9

1,379.3

1,060.6

1,704.6

1,322.3

1,516.7

Net Income to Common Incl Extra Items

1,127.9

1,379.3

1,060.6

1,704.6

1,322.3

1,516.7

Net Income to Common Excl. Extra Items

1,127.9

1,379.3

1,060.6

1,704.6

1,322.3

1,516.7

Total Shares Outstanding

343.5

348.0

353.1

357.7

350.0

352.0

Weighted Avg. Shares Outstanding

341.1

346.2

351.1

356.1

355.7

351.1

Weighted Avg. Shares Outstanding Dil

356.4

358.4

361.0

365.8

362.0

357.1

EPS

3.3

4.0

3.0

4.8

3.7

4.3

EPS Diluted

3.2

3.9

2.9

4.7

3.7

4.3

EBITDA

1,364.7

1,574.5

1,320.6

2,128.4

1,959.0

2,110.0